Myrio Therapeutics PTY LTD
Blackburn North, VIC
- UEI
- ZNWKZF5TAEU2
- CAGE
- Z16B2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- SAM.gov registration date
- Physical address
- 1/6-16 Joseph St, Blackburn North VIC 3130, Australia
- Website
- myriotx.com
- Founded
- 2009
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $51,836 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Bispecific antibodies against CT-RCC herv-e | National Heart Lung and Blood Institute (NIH) | $51,836 |
Quick answers
Is Myrio Therapeutics PTY LTD registered in SAM.gov?
Yes. Myrio Therapeutics PTY LTD's SAM.gov registration is active through April 29, 2027.
How much has Myrio Therapeutics PTY LTD received in federal contracts?
Federal contracts obligated $51,836 to Myrio Therapeutics PTY LTD in fiscal years 2023 through 2027.
What is Myrio Therapeutics PTY LTD's most recent federal award?
Myrio Therapeutics PTY LTD's most recent federal contract award is Bispecific antibodies against CT-RCC herv-e (75N92024P00043), from National Heart Lung and Blood Institute (NIH), on February 1, 2024.
On GovTribe
See Myrio Therapeutics PTY LTD's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors